A groundbreaking annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully passed an important early safety trial. Researchers have shared that the drug ...
Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...
Front desk of Ward 86, located inside of Zuckerberg San Francisco General Hospital. Photo by Julie Chang on Nov. 15, 2018. For HIV patients who struggle with daily pills — because they are homeless, ...
Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and effectively by a health care professional as in the clinic, with equally high ...
A few weeks ago, Grant Ogren and Rhea Ashby-Durall, the executive director and the outreach manager of SAN (formerly Spokane AIDS Network), met with their representative from Gilead Sciences, the ...
Viral suppression is one of the major goals of the Centers for Disease Control and Prevention (CDC) Ending the HIV Epidemic in the US (EHE) initiative. 1 Viral suppression is defined in this context ...
The FDA announced today that they've approved a twice-yearly injection for preventing HIV infection in adults and kids. News On 6's Sam Carrico spoke to an HIV specialist about what this means for ...
A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...
A new injectable solution that self-assembles into a gel under the right conditions could help manage HIV unlike any currently available methods, researchers have found. The gel releases a steady dose ...
Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who ...
BOSTON — HIV can be suppressed when the long-acting combination of cabotegravir plus rilpivirine (Cabenuva, ViiV Healthcare) is administered every 8 weeks, according to data from the ATLAS-2M study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback